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Restore Mitochondrial DysfunctionMitochondrial dysfunction is strongly associated with aging. A recent study
shows that reduced nuclear SIRT1 activity initiates age-related mitochondrial
decline through a signaling pathway that perturbs expression of genes
encoded by mitochondrial DNA. This reversible pathway has potential
anti-aging therapeutic value.Brooke E. Christian1
and Gerald S. Shadel1,2,*
Mitochondria are complex cellular
organelles that produce ATP
through the process of oxidative
phosphorylation (OXPHOS), and
there is strong evidence supporting
a causative role for dysfunctional
mitochondria in aging [1,2]. However,
the underlying mechanism of this
age-dependent mitochondrial demise
remains unclear. One explanation
that derives from the marriage of
the so-called ‘mitochondrial’ and
‘free radical’ theories of aging [3,4]
is that reactive oxygen species
(ROS) produced aberrantly during
mitochondrial electron transport
damage mitochondrial components,
including the resident mitochondrial
DNA (mtDNA). Because mtDNA
encodes essential OXPHOS protein
subunits [5], ROS-mediated mtDNA
damage and mutagenesis would
therefore disrupt OXPHOS complex
assembly and, in turn, lead to
enhanced ROS production, which
underlies increased mitochondrial
damage, cellular oxidative stress,
and tissue dysfunction that promote
aging [6] (Figure 1). However, this
theory is likely an oversimplification,
and the critical question of which
age-dependent cellular changes
precipitate the initial decline in
mitochondrial OXPHOS remains
unanswered. Now, a recent study
by Sinclair and colleagues [7] has
shed new light on this issue by showing
that alterations in nuclear gene
expression due to reduced activityof the deacetylase SIRT1 may be the
culprit. Importantly, they also show
that, by activating SIRT1 enzymatic
activity (via increasing NAD+ levels),
age-dependent mitochondrial
dysfunction, and the pathology it
promotes, could be reversed.
TounderstandhowSIRT1-dependent
changes in nuclear geneexpression can
affect mitochondria, it is important to
recall that a vast majority of thew1,500
mitochondrial proteins are encoded
by nuclear genes and imported after
synthesis in the cytoplasm. That is,
only 13 (of thew80) essential OXPHOS
subunits are encoded by the maternally
inherited mammalian mtDNA, along
with 2 rRNAs and 22 tRNAs needed
to translate the mtDNA-encoded
mRNAs on dedicated mitochondrial
ribosomes [5]. Furthermore, all
protein factors needed for expression
and maintenance of mtDNA are
nuclear gene products [8]. This
situation dictates the necessity for
signaling back-and-forth between
mitochondria and the nucleus to
ensure proper mitochondrial function
and homeostasis [9]. In fact, it is
miscommunication in one such
pathway that Gomes et al. [7] propose
is at the heart of mitochondrial
OXPHOS failure with age. Specifically,
these authors show that, in aging
mouse skeletal muscle, the expression
of mtDNA-encoded, but not
nucleus-encoded, OXPHOS subunits
is initially reduced. Most cells contain
many copies of the circular 16.5 kb
mtDNA molecule and these authors
found that aging muscle has
significantly reduced mtDNA copynumber, but no obvious changes in
the amount of mitochondria. The
ultimate explanation for this result was
that TFAM, a crucial nucleus-encoded
transcription factor required for
activationofmitochondrial transcription
and packaging of mtDNA [5], is
misregulated. Intriguingly, these
age-related changes in mitochondrial
homeostasis were largely recapitulated
in SIRT1-deficient muscle and in
culturedmyoblast cells inwhich nuclear
pools of NAD+ (an enzymatic co-factor
for SIRT1) were reduced. Thus,
mitochondrial dysfunction is perhaps
not initiated by ROS damage, but rather
by a defect in nuclear–mitochondrial
signaling (i.e. decreased expression
of the nuclear TFAM gene due to loss
of nuclear SIRT1 activity; Figure 1).
As discussed by Gomes et al. [7],
an established mechanism by which
SIRT1 regulates mitochondria is
through deacetylation of PGC-1a, a
nuclear transcriptional co-activator
that stimulates expression of nuclear
genes involved in mitochondrial
biogenesis, including TFAM [10].
Perhaps surprisingly, this is not the
pathway that is disturbed initially in
aging skeletal muscle. Instead, Gomes
et al. [7] provide strong evidence that
the SIRT1-dependent disruption of
TFAM gene expression is mediated
by stabilization of hypoxia-inducible
factor 1 alpha (HIF-1a), which in turn
inhibits the ability of c-Myc to activate
the TFAM promoter. Interestingly,
this did not involve modification of
the acetylation status of HIF-1a, but
rather downregulation of its negative
regulator, the von Hippel-Landau
protein (VHL). Control of mitochondrial
biogenesis, TFAM, and other critical
components of the mitochondrial
transcription machinery (e.g.
mitochondrial RNA polymerase and
the mitochondrial ribosomal protein
L12) by c-Myc has been documented
in previous studies [5,11,12]. Thus, it
is likely that TFAM is not the only target
of the proposed age-dependent
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Figure 1. Hypothesized time course of progression toward age-related mitochondrial
dysfunction, oxidative stress and tissue pathology.
The image shows the nucleus and a mitochondrion of a muscle cell undergoing age-related
changes. Based on the study by Gomes et al. [7], the initial decline in nuclear NAD+ leads to a
reduction of SIRT1 deacetylase activity, stabilization of HIF-1a, inactivation of c-Myc, and
decreased expression of the TFAM gene (Phase I). Fewer TFAM molecules (and likely other
mitochondrial regulatory factors as well) in mitochondria cause reduced mitochondrial gene
expression and OXPHOS activity (Phase I). Following this initial OXPHOS decline, reduced
expression of nuclear-encoded OXPHOS subunits ensues, leading to a more severe disruption
in OXPHOS complex assembly and increased ROS production (Phase II). This sets into play a
vicious cycle in which ROS damage mtDNA and OXPHOS complexes, resulting in yet more
mitochondrial ROS production (Phase III). Eventually this situation escalates to cause global
cellular oxidative stress that promotes age-related tissue dysfunction and pathology (Phase IV).
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R207is causing the observed decline in
mtDNA and mtDNA-encoded OXPHOS
subunits. In fact, Gomes et al. [7] did
not directly address whether TFAM
protein is downregulated in aging
skeletal muscle as predicted. In
addition, it remains unclear whether it
is mtDNA depletion per se, the loss
of transcriptional functions of TFAM,
or both of these mechanisms that
underlies the observed decrease in
mtDNA-encoded OXPHOS subunits.
This is important when considering
previous conflicting results onage-dependent changes to TFAM
levels and mtDNA copy number in
mammalian tissues [13,14]. Thus,
while the Gomes et al. [7] study reports
mtDNA depletion with age in muscle
(driven by TFAM reduction) and
clearly describes how disruption of
a newly identified signaling pathway
can account for age-dependent
mitochondrial dysfunction, there
remains room for additional verification
of this provocative model and
delineation of the precise mechanisms
involved.A key finding by Gomes et al. [7] that
is of potential anti-aging therapeutic
value is that the reduction in
mitochondrial OXPHOS function and
several features of muscle pathology
of 22-month-old mice are reversed
by a one-week treatment with
nicotinamide mononucleotide (NMN),
which promotes NAD+ biosynthesis.
NMN has been previously shown to
be effective in reversing age-related
type 2 diabetes [15]. Together, these
studies suggest that decreased
mitochondrial OXPHOS may underlie
multiple age-related pathologies and
that upregulating SIRT1 activity may
help reverse this through the newly
discovered pathway. Interestingly,
caloric restriction also reversed the
age-dependent increase in HIF-1a and
the decline in VHL function, consistent
with the ability of caloric restriction to
increase SIRT1 and NAD+ in mammals
and increase lifespan in many
organisms [16]. While Gomes et al. [7]
demonstrate that many of the effects
of NMN supplementation and caloric
restriction inmuscle are likelymediated
through this nuclear SIRT1-dependent
pathway, NMN supplementation would
presumably increase other subcellular
pools of NAD+ as well. Several sirtuins
are located in mitochondria and
SIRT3, in particular, has been shown
to mediate some beneficial effects
of caloric restriction and regulate
TFAM acetylation [17]. Thus, an
intriguing possibility is that NMN
supplementation and/or caloric
restriction are working through the
modulation of both mitochondrial
and nuclear NAD+ pools to achieve
maximal benefit. Conversely, if
modulation of only the nuclear NAD+
pool is beneficial, global NMN
supplementation could have
unintended side effects. For example,
altering the mitochondrial NAD+:NADH
ratio can directly affect OXPHOS
activity and mitochondrial ROS
formation [18], which may impact ROS
signaling or promote oxidative stress.
Placing the Gomes et al. [7] study in
the context of the mitochondrial and
free radical theories of aging provides a
nice explanation of how mitochondrial
dysfunction in aging, at least in muscle,
is initiated. That is, reduced NAD+
levels in the nucleus promote a decline
in expression of mtDNA-encoded
subunits by the proposed
SIRT1–HIF-1a–c-Myc–TFAM pathway.
Onemight predict that thiswould cause
one of several well-documented
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the mitochondrial unfolded protein
response) or an increase in ROS
production. However, Gomes et al. [7]
conclude that neither of these is
involved in the muscle responses
they observe. Nonetheless, they do
report a later significant increase in
ROS after AMP kinase is activated and
when both mtDNA-encoded and
nuclear-encoded OXPHOS subunits
are declining (the so-called second,
PGC-1a-dependent phase of the
response). We offer an extended
interpretation of their results that
highlights a potential involvement of
ROS (Figure 1). That is, we agree
that nuclear NAD+ depletion could
initiate OXPHOS dysfunction by the
SIRT1–HIF-1a–c-Myc–TFAM pathway
proposed, but posit that this eventually
leads to increased ROS production
when the secondphase of the response
commences, characterized by a
global disruption of OXPHOS gene
expression caused by a reduction in
both mtDNA- and nuclear-encoded
OXPHOS subunits. This, coupled
with the pseudo-hypoxic state (i.e.
upregulation of HIF-1a) as discussed
by Gomes et al. [7], likely promotes
increased ROS production, oxidative
stress, and age-related pathology.
Clearly, the role of mitochondria in
aging requires much more effort to
resolve. We believe the Gomes et al. [7]
study provides strong evidence for a
novel initiating event for eventual
mitochondrial decline that falls in line
with the mitochondrial free radical
theory of aging (Figure 1). But, at the
same time, there is substantial
evidence that mitochondrial stress
(e.g. ROS and electron transportchain dysfunction) can extend lifespan
by engaging retrograde signaling
pathways that signal back to the
nucleus [19,20], some of which involve
HIF-1a. The excitement and challenge
going forward will be to determine
precise mechanisms through which
mitochondrial dysfunction and
signaling can have both beneficial
and deleterious effects on aging, and
whether these pathways can be
augmented or prevented to extend
human healthspan and longevity.References
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